Board MeetingOutcome of Board Meeting
IOL Chemicals & Pharma's Board has approved the financial results for the quarter ended June 30, 2026. Consolidated Revenue from Operations soared to ₹756.26 Cr, with Net Profit reaching ₹64.40 Cr and EPS at ₹2.19.
IOL Chemicals and Pharmaceuticals LimitedIOLCP · Filed with the exchange
No comments yet. Be the first.